Nanoparticulate Drug Delivery Systems
Deepak Thassu · Michel Deleers · Yashwant Vishnupant Pathak
maalis 2007 · CRC Press
3,0star
3 arvosteluareport
E-kirja
376
sivuja
family_home
Kelvollinen
info
reportArvioita ja arvosteluja ei ole vahvistettu Lue lisää
Tietoa tästä e-kirjasta
With the advent of analytical techniques and capabilities to measure particle sizes in nanometer ranges, there has been tremendous interest in the use of nanoparticles for more efficient methods of drug delivery. Nanoparticulate Drug Delivery Systems addresses the scientific methodologies, formulation, processing, applications, recent trends, and e
Arviot ja arvostelut
3,0
3 arvostelua
Tietoja kirjoittajasta
UCB Pharma, Inc., Rochester, New York. He is responsible for developing IEDS technology, which is used to formulate extended release suspensions. During his fifteen-year career, he has led the development of several marketed extended release products and has published numerous scientific articles in the field of oral and transdermal drug delivery systems. Dr. Thassu holds several US and European patents and received the M. Pharm. degree in pharmaceutics (1986) from Saugor University, India, the Ph.D. degree in pharmaceutical sciences (1991) from the University of Cincinnati, Ohio, and the MBA degree (2007) from Cornell University, Ithaca, New York. MICHEL DELEERS is Vice President, Global Pharmaceutical Technology and Analytical Development and Clinical Supplies for UCB Pharma, Chemin du Foriest, Braine l’Alleud, Belgium, responsible for developing products with new drug delivery systems, new nano and microparticulate systems, and alternative routes of adminstration for insoluble and biological drugs. He received the Ph.D. degree in chemical sciences (1978) and the D.Sc. degree (1986) from the Université Libre de Bruxelles, Belgium. A member of the Royal Chemical Society of Belgium, the International Pharmaceutical Federation (FIP), and the American Association of Pharmaceutical Scientists (AAPS), Dr. Deleers has published more than 125 scientific articles and has obtained 20 patents. YASHWANT PATHAK is currently Director, Research and Development for PharmaFab, Grand Prairie, Texas, a company providing contract research services for specialized drug delivery systems. The author of over 100 research publications, including several papers on sub-micronized emulsions and PLA: PLGA nano-particles, he began his career as a Lecturer in pharmaceutics at Delhi University, New Delhi, India. Dr. Pathak received the Ph.D. degree from Nagpur University, India and was awarded a fellowship from the American Heart Association to complete research on cardiovascular drug delivery systems.
Arvioi tämä e-kirja
Kerro meille mielipiteesi.
Tietoa lukemisesta
Älypuhelimet ja tabletit
Asenna Google Play Kirjat ‑sovellus Androidille tai iPadille/iPhonelle. Se synkronoituu automaattisesti tilisi kanssa, jolloin voit lukea online- tai offline-tilassa missä tahansa oletkin.
Kannettavat ja pöytätietokoneet
Voit kuunnella Google Playsta ostettuja äänikirjoja tietokoneesi selaimella.
Lukulaitteet ja muut laitteet
Jos haluat lukea kirjoja sähköisellä lukulaitteella, esim. Kobo-lukulaitteella, sinun täytyy ladata tiedosto ja siirtää se laitteellesi. Siirrä tiedostoja tuettuihin lukulaitteisiin seuraamalla ohjekeskuksen ohjeita.
